Próximo curso

Fecha 04-07 Junio 2018

XII Curso Intensivo de Terapia Electroconvulsiva (2018)

Más información

Último congreso

Fecha 20-21 Junio 2014

Relevance of Staging Psychotic disorders as a Paradigm-shift for understanding disease progression and stage-dependent treatment.

Más información

Últimas Publicaciones

STRATEGIES FOR STUDYING BRAIN DISORDERS

Vol.9 Sistema Dopaminérgico y Trastornos Psiquiátricos

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

June 2013

ISBN: 978-1-4614-7263-6

Publicaciones

Vol.2 Schizophrenia, Movement Disorders, and Age Related Cognitive Disorders

Vol.2 Schizophrenia, Movement Disorders, and Age Related Cognitive Disorders

June 1994

Editores: Tomás Palomo, Richard J. Beninger, Trevor Archer

Editorial: Editorial Complutense, Donoso Cortés, 65, 28015 MADRID

ISBN: 84-7491-504-X

Páginas: 434

Más información

Also found within the publications are contributions presented at the meeting held in Madrid in 1992.

Tabla de contenidos
  1. Psychotic disorders
    1. Strategies for the Choice of Animal Models in the Evaluation ofAtypical Antipsychotic Drugs .S. Ahlenius
    2. Role of Olfactory Tubercle and Nucleus Accumbens in the effects ofClassical and Atypical Neuroleptics: search for regional specificity.A.R. Cools, E.P.M. Prinssen, B A. Ellenbroek and D J. Heeren
    3. Yawning induced by Low Doses of Apomorphine as a Possible BiologicalMarker for Studying the effects of CNS Active Compounds on theDopamine System .M. Casas, G. Prat, J. Guardia and P. Duro
    4. Remoxipride - Preclinical Predictions and Clinical Outcome .T.Lewander, D.M. Jackson, M. Blomqvist, S. Ogenstad and B. Gustafsson
    5. Potential Mechanisms underlying the Atypical Antipsychotic Profile ofRemoxipride .S.O. Ögren
    6. A Clinician's View of Animal Research in Schizophrenia Studies .T.Palomo
    7. Ondansetron: a double-blind, placebo-controlled study in acuteschizophrenia. .J. Wilson, P.G. Cooksey and S.L. McBain
    8. Clinical Characteristics of Atypical Antipsychotic Drugs .B.Woggon
    9. Sertindole -an Atypical Neuroleptic .C. Sánchez
  2. Movement disorders
    1. Neuroanatomical Consequences of Psychostimulant Drugs: effects afteradult and prenatal exposure .P.M. Groves, D. Jackson, J.C. Linder,M.S. Manley, L.J. Ryan and S.J. Young
    2. The Peculiar Pharmacology of Bromocriptine .D.M. Jackson, J.A.Watson and S.B. Ross
    3. MPTP-induced Behavioural Deficits in Mice: validity and utility of amodel of parkinsonism .A. Fredriksson and T. Archer
    4. Huntington's Disease: behavioral pathology and animal models .D.F.Emerich, T.B. Freeman, D.W. Cahill, C.W. Olanow and P.R. Sanberg
    5. Parkinson's Disease: PET, pharmacokinetics and therapeutic strategies.S.M. Aquilonius
    6. Neurotrophic Factors for the Treatment of Neurological Disorders: themodel of Parkinson's disease .M. Angeles Mena, M. JoséCasajeros and J. Garcia de Yébenes
    7. Rehabilitation of Patients with Parkinson's .A. Portera-Sánchez
  3. Cognitive disorders
    1. Critical Issues in Cognition Enhancing Drug Research .R.Porsolt,S. Roux and A. Lenègre
    2. Dopaminergic-Cholinergic Function in Neo-Striatal Memory Function:role of nigro-striatal terminals .N.M. White, M. Viaud and M.G.Packard
    3. Glutamatergic Receptors, Learning and Dementia: implications for theupdate of screening methods .W. Danysz and W.J. Schmidt
    4. Memory Processing by the Amygdala, Hippocampus and Entorhinal Cortex:role of glutamatergic and GABA-A receptors .I. Izquierdo
    5. Strategies "in Search of the Engram": a half-century later.R.W. Russell
    6. ACTH Neuropeptides and Recovery from Brain Injury .D. de Wied
    7. Effects of ACTH Neuropeptides on Nerve Repair and Neuropathy: animaland human studies .W.H. Gispen, A.C. Kappelle, B. Bravenboer,F.P.T. Hamers and P.M. Edwards
    8. Developing and Regenerating Systems as Models tor Trophic Effects ofACTH Neuropeptides .F.L. Strand, S.E. Alves, F.J. Antonawich, S.J.Lee, T.S. Lee and L.A. Zuccarelli
    9. The ICD-10 Classification of Dementias .J.J. López-Ibor
    10. Clinical Features of Alzheimer's Disease .D.G. Cole and J.H.Growdon

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+